Stock Taper 
TFX
$139.67
▲ UP 1.42% (1.96)
KEY STATISTICS
Market Cap$6.18 B
52w High$145.00
52w Low$100.18
Dividend Yield1.01%
FrequencyQuarterly
P/E15.96
Volume428.33K
Shares Out.44.27M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Jason Weidman
COMPENSATION 2026
Salary$1,144,400
Stock Awards$2,005,604
Incentive Plan Pay$227,280
All Other Comp.$325,566
Total$6,732,419
ABOUT
SECTOR
Healthcare
WENT PUBLIC
March 17, 1980
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
15,500
PRICE TARGET
Target High$170.00
Target Low$140.00
Target Median$156.50
Target Consensus$155.25
UPCOMING EARNINGS
DateNov 5, 2026
DayThursday
Rev. Est.$565.37M
NOV
5
THU
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 1997-06-17 | Forward | 2:1 |
| 1991-06-17 | Forward | 3:2 |
| 1986-06-17 | Forward | 2:1 |
| 1981-09-16 | Forward | 3:2 |
| 1980-12-16 | Forward | 2:1 |
| 1978-06-16 | Forward | 2:1 |
| 1977-01-20 | Forward | 21:20 |
| 1976-01-09 | Forward | 1049:1000 |
| 1975-01-08 | Forward | 1049:1000 |
PRICE
$139.67 ▲ UP 1.42% (+$1.96)About Teleflex Incorporated
https://www.teleflex.com ↗Teleflex Incorporated designs and supplies single-use medical devices for critical care, surgical, urology, and respiratory applications worldwide, serving healthcare providers, manufacturers, and home care markets.
INDUSTRY
Medical - Instruments & Supplies
A PRODUCT TELEFLEX INCORPORATED IS KNOWN FOR
UroLift™ 2 System with Advanced Tissue Control
The UroLift™ 2 System with Advanced Tissue Control, launched in April 2024, is a minimally invasive, customizable platform that enhances BPH treatment by improving efficiency and physician confidence across diverse prostate types.
Revenue by Products
| Icon | PRODUCT | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Vascular Access | $191.02M | $358.81M ▲ | $236.81M ▼ | $246.34M ▲ |
 | Interventional | $266.41M | $73.8M ▼ | $204.66M ▲ | $211.87M ▲ |
 | Surgical | $122.88M | $75.45M ▼ | $106.79M ▲ | $112.12M ▲ |
 | Anesthesia | $101.45M | — | — | — |
 | Interventional Urology | $71.77M | — | — | — |
 | Other | $79.08M | $0 ▼ | — | — |
Revenue by Geography
| Map | REGION | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 |
|---|---|---|---|---|---|
 | Americas Segment | $555.9M | — | $332.65M ▼ | $348.84M ▲ |
 | EMEA | $234.25M | $0 ▼ | $146.68M ▲ | $145.53M ▼ |
 | Asia | $122.87M | $0 ▼ | $68.93M ▲ | $75.96M ▲ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
205
LISTED HERE
26
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
83.20%
HOLDERS
748
TOP 12 OF 748 · RANKED BY POSITION SIZE
Blackrock, Inc.
Vanguard Group Inc
T. Rowe Price Investment Management, Inc.
Janus Henderson Group Plc
Blackrock Inc.
Morgan Stanley
Aqr Capital Management LLC
Janus Henderson Investors Us LLC
Blackrock Fund Advisors
Baupost Group LLC/Ma
Sessa Capital Im, L.P.
State Street Corp
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow4
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book3
Overall Score2
TRADES BY CONGRESS
HOUSE TRADES
Lisa McClain
Sale (Full)
2025-07-22
Rob Bresnahan
Sale
2025-02-25
Ro Khanna
Sale
2023-10-02
Daniel Goldman
Sale
2023-07-12
INSIDER TRADES
★
DIRECTOR
RANDLE STUART A
Purchase · 995 shares
2026-06-08
★
DIRECTOR
RANDLE STUART A
Sale · 4.1K shares
2026-06-07
★
DIRECTOR
RANDLE STUART A
Purchase · 2.2K shares
2026-06-08
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Weidman Jason R.
Purchase · 54.0K shares
2026-06-08
MOST RECENT ANALYST GRADES
GRADE SUMMARY
NEUTRAL 2
OUTPERFORM 2
BUY 1
HOLD 1
OVERWEIGHT 1
EQUAL WEIGHT 1
8 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 ARWR | $84.91 | COMPARE |
 KRYS | $351.46 | COMPARE |
 PCVX | $59.84 | COMPARE |
 TGTX | $53.93 | COMPARE |
 ALKS | $47.41 | COMPARE |
 BLCO | $17.15 | COMPARE |
 PTCT | $70.09 | COMPARE |
 STVN | $21.03 | COMPARE |